Site Members can sign up for company wide alerts
Investigation Overview
In response to the buyout offer by Pfizer to take over King Pharmaceuticals, Inc. at $14.25 an investigation on behalf of investors of King Pharmaceuticals, Inc. (NYSE:KG) over possible breaches of fiduciary duties in connection with the proposed takeover was announced. The investigation by a law firm concern whether King Pharmaceuticals and its Board of Directors breached their fiduc...
You must register (for free) or login to view the entire investigation.